Market
What will be the legal status of telemedicine abortion services in the US by end of 2025?
2
Resolution / Starting Odds
Nationally restricted • 25%
Allowed in some states • 25%
Nationally allowed • 25%
Status quo remains • 25%
Federal and state court decisions, legislative actions
Story
Texas AG Paxton Sues NY Doctor in First Challenge to Shield Law Over Abortion Pills
Dec 13, 2024, 08:22 PM
Texas Attorney General Ken Paxton has filed a lawsuit against a New York doctor, accusing her of illegally prescribing and mailing abortion pills to a Texas woman in violation of Texas state law, including the Human Life Protection Act. The lawsuit alleges that the doctor provided the medication via telemedicine, leading the woman to seek emergency medical care. This case marks Texas's first legal action against an out-of-state abortion provider and the first challenge to shield laws enacted by Democratic-controlled states like New York, which aim to protect doctors from out-of-state prosecution. The lawsuit underscores Paxton's ongoing efforts to further restrict abortion access in Texas and sets the stage for a significant legal battle over interstate telemedicine and conflicting state abortion laws.
View original story
Similar markets
No action • 25%
Introduce new federal law • 25%
Challenge state laws • 25%
Issue federal guidance • 25%
No • 50%
Yes • 50%
Prohibited • 33%
Allowed • 33%
Restricted • 33%
No Change • 1%
Stricter regulations • 25%
No change • 25%
Mixed outcomes • 25%
Looser regulations • 25%
Florida • 25%
Texas • 25%
Other • 25%
Missouri • 25%
Equal usage of pills and surgery • 25%
Surgical procedures • 25%
Abortion pills • 25%
Other methods • 25%
Amendment failed • 25%
No action taken • 25%
Amendment delayed • 25%
Amendment passed • 25%
Majority approval • 25%
Majority disapproval • 25%
Mixed opinions • 25%
Indifferent/No opinion • 25%
Not passed • 25%
Passed and enacted • 25%
Passed but blocked • 25%
Other • 25%
States win, FDA regulations changed • 25%
Settled out of court • 25%
States lose, FDA regulations unchanged • 25%
States win, FDA regulations unchanged • 25%